|
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (USD $)
|
Total
|
Issuance During Period 1st
|
Issuance During Period 2nd
|
Issuance During Period 3rd
|
Accounts Payable
Issuance During Period 1st
|
Accounts Payable
Issuance During Period 2nd
|
Notes Payable
Issuance During Period 3rd
|
Common Stock
|
Common Stock
Issuance During Period 1st
|
Common Stock
Issuance During Period 2nd
|
Common Stock
Issuance During Period 3rd
|
Common Stock
Accounts Payable
Issuance During Period 1st
|
Common Stock
Accounts Payable
Issuance During Period 2nd
|
Common Stock
Notes Payable
Issuance During Period 3rd
|
Additional Paid-in Capital
|
Additional Paid-in Capital
Issuance During Period 1st
|
Additional Paid-in Capital
Issuance During Period 2nd
|
Additional Paid-in Capital
Issuance During Period 3rd
|
Additional Paid-in Capital
Accounts Payable
Issuance During Period 1st
|
Additional Paid-in Capital
Accounts Payable
Issuance During Period 2nd
|
Additional Paid-in Capital
Notes Payable
Issuance During Period 3rd
|
Deficit Accumulated during the Development Stage
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beginning Balance at Oct. 13, 2010 | ||||||||||||||||||||||
| Issuance of Units at $0.033 per share (in shares) | 300,000 | |||||||||||||||||||||
| Issuance of Units at $0.033 per share | $ 10,000 | $ 3 | $ 9,997 | |||||||||||||||||||
| Issuance of common stock (in shares) | 60,000,000 | |||||||||||||||||||||
| Issuance of common stock | 20,000 | 600 | 19,400 | |||||||||||||||||||
| Net loss | (50,855) | (50,855) | ||||||||||||||||||||
| Ending Balance at Dec. 31, 2010 | (20,855) | 603 | 29,397 | (50,855) | ||||||||||||||||||
| Ending Balance (in shares) at Dec. 31, 2010 | 60,300,000 | |||||||||||||||||||||
| Issuance of Units at $0.033 per share (in shares) | 5,865,000 | 2,437,500 | 562,500 | |||||||||||||||||||
| Issuance of Units at $0.033 per share | 195,500 | 81,250 | 18,750 | 59 | 24 | 6 | 195,441 | 81,226 | 18,744 | |||||||||||||
| Share based compensation (in shares) | 285,000 | |||||||||||||||||||||
| Share based compensation | 18,109 | 3 | 18,106 | |||||||||||||||||||
| Issuance of common stock (in shares) | 1,500,000 | |||||||||||||||||||||
| Issuance of common stock | 50,000 | 15 | 49,985 | |||||||||||||||||||
| Effect of reverse merger recapitalization on December 29, 2011 (in shares) | 4,829,872 | |||||||||||||||||||||
| Effect of reverse merger recapitalization on December 29, 2011 | (451,915) | 48 | (451,963) | |||||||||||||||||||
| Conversion to common stock (in shares) | 844,860 | 906,825 | 7,500,000 | |||||||||||||||||||
| Conversion to common stock | 28,162 | 90,682 | 167,585 | 8 | 9 | 75 | 28,154 | 90,673 | 167,510 | |||||||||||||
| Net loss | (571,601) | (571,601) | ||||||||||||||||||||
| Ending Balance at Dec. 31, 2011 | (394,333) | 850 | 227,273 | (622,456) | ||||||||||||||||||
| Ending Balance (in shares) at Dec. 31, 2011 | 85,031,557 | |||||||||||||||||||||
| Share based compensation | 1,870 | 1,870 | ||||||||||||||||||||
| Net loss | (98,955) | (98,955) | ||||||||||||||||||||
| Ending Balance at Mar. 31, 2012 | $ (491,418) | $ 850 | $ 229,143 | $ (721,411) | ||||||||||||||||||
| Ending Balance (in shares) at Mar. 31, 2012 | 85,031,557 |